# Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

> **NCT01633645** · PHASE2 · COMPLETED · sponsor: **University Hospital of Crete** · enrollment: 53 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Metastatic

## Interventions

- **DRUG:** Bortezomib
- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01633645
- **Lead sponsor:** University Hospital of Crete
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633645, "Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01633645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*